Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Nov / Improving ICU Infection Predictions
Technology and innovation Infectious Disease Clinical care Research and Innovations

Improving ICU Infection Predictions

New machine learning approach aids clinicians in predicting bloodstream infections and drug resistance using readily available patient data

By Jessica Allerton 11/11/2024 News 1 min read

Share

A new machine learning model, called multi-objective symbolic regression (MOSR), shows promise in predicting bloodstream infections (BSI) and antimicrobial resistance (AMR) in ICU patients. Developed by researchers from King’s College London and Guy’s and St. Thomas’ NHS Trust, the model uses data available at ICU admission to guide timely infection treatment decisions.

Credit: Adobe Stock

Traditional machine learning methods have struggled with the high data imbalance typically seen in ICU infection cases. However, MOSR, which produces interpretable equations, can work with imbalanced datasets and achieve high prediction accuracy. In this study, MOSR consistently outperformed conventional models, with F1-Scores 0.28 points higher than the best-performing alternatives​.

The study involved 1,142 ICU patients and used 25 factors related to infection risk, including mean arterial pressure, bicarbonate, urea, and white blood cell count. The MOSR model prioritized sensitivity to minimize false negatives, which is critical for ICU infection control. MOSR demonstrated an AUROC score of 0.79 for BSI prediction and 0.86 for AMR, surpassing all other models tested. In leveraging routinely available patient data, MOSR provides a scalable tool that can be implemented across ICUs without the need for deep learning infrastructure.

“An important way to tackle the grave threat of antimicrobial resistance is to protect the antibiotics we already have, which goes hand in hand with the urgent need for fast diagnostics,” explains Lindsey Edwards, expert in microbiology at King’s College London, in the press release. “Using AI to speed up the diagnostics of infection [...] could not only have a huge impact on the patient’s survival and their care outcomes; but could help to preserve the antibiotics we already have developed and prevent the development of further antibiotic resistance."

This research has paved the way for further ongoing studies to validate MOSR’s effectiveness across ICU’s. The researchers hope more testing could fulfill the regulatory requirements for deployment of this AI approach across the NHS.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.